Vectivbio raised €127M in a funding round in Oct 2022. The company is based in Basel, Switzerland. Investors in the round: Cowen Healthcare Investments, Driehaus Capital Management, Eventide Asset Management and 8 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
